February 2013 tender notification
The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the Invitation to Tender, dated 31 October 2012.
As discussed in our 2010 tender consultation document, we are notifying tender decisions as they are made in 2013. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.